• Featured Product
  • KD/KO Validated

NRF2, NFE2L2 Recombinant antibody, PBS Only

NRF2, NFE2L2 Recombinant Antibody for WB, IP, IF, IHC, Indirect ELISA

Host / Isotype

Rabbit / IgG

Reactivity

Human, mouse

Applications

WB, IP, IF, IHC, Indirect ELISA

Conjugate

Unconjugated

CloneNo.

1I21

Cat No : 80593-1-PBS

Print datasheet

Synonyms

HEBP1, NF E2 related factor 2, NFE2 related factor 2, NFE2L2, NRF2



Planning an IHC experiment? We recommend our IHCeasy NFE2L2/NRF2 Ready-To-Use IHC Kit. NFE2L2/NRF2 primary antibody included.

产品信息

80593-1-PBS targets NRF2, NFE2L2 in WB, IP, IF, IHC, Indirect ELISA applications and shows reactivity with Human, mouse samples.

Tested Applications WB, IP, IF, IHC, Indirect ELISA Application Description
Tested Reactivity Human, mouse
Immunogen NRF2, NFE2L2 fusion protein Ag9489 种属同源性预测
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Full Name nuclear factor (erythroid-derived 2)-like 2
Synonyms HEBP1, NF E2 related factor 2, NFE2 related factor 2, NFE2L2, NRF2
Calculated Molecular Weight 605 aa, 68 kDa
Observed Molecular Weight110 kDa
GenBank Accession NumberBC011558
Gene Symbol NFE2L2
Gene ID (NCBI) 4780
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDQ16236
Storage Buffer PBS Only
Storage ConditionsStore at -80°C.

背景介绍

NRF2, also named as NFE2L2, belongs to the bZIP family and CNC subfamily. It is a transcription activator that binds to antioxidant response (ARE) elements in the promoter regions of target genes. NRF2 is important for the coordinated up-regulation of genes in response to oxidative stress. It may be involved in the transcriptional activation of genes of the beta-globin cluster by mediating enhancer activity of hypersensitive site 2 of the beta-globin locus control region. Nrf2 is a key player in the regulation of genes encoding for many antioxidative response enzymes.The expression of NRF2 may be induced under oxidative stress (PMID:14567983).In lung cancer, Nrf2 activation in malignant cells has been associated with tumor progression and chemotherapy resistance(PMID:20534738). Identifying patients with abnormal NRF2 expression may be important for selection for chemotherapy in NSCLC. As new investigators break into the emerging field of Nrf2 research, confusion regarding the correct migratory pattern of Nrf2 is causing doubts about the accuracy and reproducibility of published results. This letter provides solid evidence that the actually observed molecular weight of Nrf2 is about 70kDa and 95-110 kDa. (PMID: 22703241).